289 related articles for article (PubMed ID: 32603034)
1. Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non-ischaemic dilated cardiomyopathy: a meta-analysis.
Wang J; Yang F; Wan K; Mui D; Han Y; Chen Y
ESC Heart Fail; 2020 Oct; 7(5):2184-2192. PubMed ID: 32603034
[TBL] [Abstract][Full Text] [Related]
2. Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.
Halliday BP; Gulati A; Ali A; Guha K; Newsome S; Arzanauskaite M; Vassiliou VS; Lota A; Izgi C; Tayal U; Khalique Z; Stirrat C; Auger D; Pareek N; Ismail TF; Rosen SD; Vazir A; Alpendurada F; Gregson J; Frenneaux MP; Cowie MR; Cleland JGF; Cook SA; Pennell DJ; Prasad SK
Circulation; 2017 May; 135(22):2106-2115. PubMed ID: 28351901
[TBL] [Abstract][Full Text] [Related]
3. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.
Gulati A; Jabbour A; Ismail TF; Guha K; Khwaja J; Raza S; Morarji K; Brown TD; Ismail NA; Dweck MR; Di Pietro E; Roughton M; Wage R; Daryani Y; O'Hanlon R; Sheppard MN; Alpendurada F; Lyon AR; Cook SA; Cowie MR; Assomull RG; Pennell DJ; Prasad SK
JAMA; 2013 Mar; 309(9):896-908. PubMed ID: 23462786
[TBL] [Abstract][Full Text] [Related]
4. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.
Disertori M; Rigoni M; Pace N; Casolo G; Masè M; Gonzini L; Lucci D; Nollo G; Ravelli F
JACC Cardiovasc Imaging; 2016 Sep; 9(9):1046-1055. PubMed ID: 27450871
[TBL] [Abstract][Full Text] [Related]
5. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
[TBL] [Abstract][Full Text] [Related]
6. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
Kuruvilla S; Adenaw N; Katwal AB; Lipinski MJ; Kramer CM; Salerno M
Circ Cardiovasc Imaging; 2014 Mar; 7(2):250-258. PubMed ID: 24363358
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis.
Anagnostopoulos I; Kousta M; Kossyvakis C; Lakka E; Paraskevaidis NT; Schizas N; Alexopoulos N; Deftereos S; Giannopoulos G
J Interv Card Electrophysiol; 2022 Apr; 63(3):523-530. PubMed ID: 34218421
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.
He D; Ye M; Zhang L; Jiang B
Heart Lung; 2018; 47(2):122-126. PubMed ID: 29174363
[TBL] [Abstract][Full Text] [Related]
9. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.
Di Marco A; Anguera I; Schmitt M; Klem I; Neilan TG; White JA; Sramko M; Masci PG; Barison A; Mckenna P; Mordi I; Haugaa KH; Leyva F; Rodriguez Capitán J; Satoh H; Nabeta T; Dallaglio PD; Campbell NG; Sabaté X; Cequier Á
JACC Heart Fail; 2017 Jan; 5(1):28-38. PubMed ID: 28017348
[TBL] [Abstract][Full Text] [Related]
10. Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy.
Ota S; Orii M; Nishiguchi T; Yokoyama M; Matsushita R; Takemoto K; Tanimoto T; Hirata K; Hozumi T; Akasaka T
J Cardiovasc Magn Reson; 2021 Mar; 23(1):32. PubMed ID: 33761955
[TBL] [Abstract][Full Text] [Related]
11. Septal Midwall Late Gadolinium Enhancement in Ischemic Cardiomyopathy and Nonischemic Dilated Cardiomyopathy-Characteristics and Prognosis.
Becker MAJ; van der Lingen ACJ; Cornel JH; van de Ven PM; van Rossum AC; Allaart CP; Germans T
Am J Cardiol; 2023 Aug; 201():294-301. PubMed ID: 37393732
[TBL] [Abstract][Full Text] [Related]
12. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.
Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of late gadolinium enhancement in dilated cardiomyopathy patients. A meta-analysis.
Shi HW; Pu P; Deng W; Zhou H; Bian ZY; Shen DF; Xie J; Salerno M; Tang QZ
Saudi Med J; 2013 Jul; 34(7):719-26. PubMed ID: 23860892
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and prognostic value of right ventricular (dys)function in patients with non-ischaemic dilated cardiomyopathy assessed with cardiac magnetic resonance imaging.
Becker MAJ; van der Lingen ACJ; Wubben M; van de Ven PM; van Rossum AC; Cornel JH; Allaart CP; Germans T
ESC Heart Fail; 2021 Apr; 8(2):1055-1063. PubMed ID: 33560582
[TBL] [Abstract][Full Text] [Related]
15. Cardiac MRI Risk Stratification for Dilated Cardiomyopathy with Left Ventricular Ejection Fraction of 35% or Higher.
Li S; Wang Y; Yang W; Zhou D; Zhuang B; Xu J; He J; Yin G; Fan X; Wu W; Sharma P; Sirajuddin A; Arai AE; Zhao S; Lu M
Radiology; 2023 Mar; 306(3):e213059. PubMed ID: 36318031
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.
Green JJ; Berger JS; Kramer CM; Salerno M
JACC Cardiovasc Imaging; 2012 Apr; 5(4):370-7. PubMed ID: 22498326
[TBL] [Abstract][Full Text] [Related]
17. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.
Neilan TG; Coelho-Filho OR; Danik SB; Shah RV; Dodson JA; Verdini DJ; Tokuda M; Daly CA; Tedrow UB; Stevenson WG; Jerosch-Herold M; Ghoshhajra BB; Kwong RY
JACC Cardiovasc Imaging; 2013 Sep; 6(9):944-54. PubMed ID: 23932642
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Kamp NJ; Chery G; Kosinski AS; Desai MY; Wazni O; Schmidler GS; Patel M; Lopes RD; Morin DP; Al-Khatib SM
Prog Cardiovasc Dis; 2021; 66():10-16. PubMed ID: 33171204
[TBL] [Abstract][Full Text] [Related]
19. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]